Outpatient Randomized Controlled Trials in the Covid-19 Era and Beyond.

ABSTRACT

Outpatient Trials in the Covid-19 Era and BeyondA group of investigators had a meeting at the National Heart, Lung, and Blood Institute in May 2020 to discuss ways to decrease thrombotic complications among symptomatic outpatients with Covid-19. The investigators discuss their approach to three specific challenges conducting a trial remotely, working through regulatory hurdles, and recruiting a diverse population of participants.